<?xml version="1.0" encoding="UTF-8"?>
<p>Another host-target compound is Saracatinib (AZD0530), a tyrosine kinase (SFK) inhibitor. This compound suppressed the early stages of the MERS-CoV replicative cycle in Huh7 cells (EC
 <sub>50</sub> of 2.9 μM and CC
 <sub>50</sub> &gt; 50 μM), possibly by affecting the SFK pathways (
 <xref rid="B203" ref-type="bibr">Shin et al., 2018</xref>). SFK possesses a central function in signaling pathways such as ERK/MAPK and PI3K/AKT (
 <xref rid="B216" ref-type="bibr">Thomas and Brugge, 1997</xref>), which are strictly related to CoV infection. Therefore, SFK inhibition might promote viral clearance and can be used in association with other drugs (
 <xref rid="B203" ref-type="bibr">Shin et al., 2018</xref>).
</p>
